Monitoring molecular changes after kidney transplantation
Official title: Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation
Run by Odense University Hospital · NCT01515605 · Data updated 2026-11-12
This study is testing if checking blood and tissue samples can help doctors spot problems early and improve outcomes for people who have received a kidney transplant.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Odense University Hospital Academic / other |
| Locations | 1 site (Odense, DK) |
| Status | Recruiting |
| Started | January 1, 2011 |
| Main results expected | March 31, 2033 |
| Study ends | March 31, 2033 |
| Registry record updated | March 28, 2023 |
| Trial ID | NCT01515605 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals who have recently undergone kidney transplantation and can provide informed consent.
✕Probably not a fit
Patients who are unable to provide informed consent or have not undergone kidney transplantation will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on the molecular monitoring of patients who have undergone kidney transplantation. It evaluates blood, plasma, urine, and tissue samples to assess the effectiveness of noninvasive diagnostic techniques in improving transplant outcomes. The study involves routine clinical and laboratory data collection at various time points post-transplantation, analyzing gene transcripts and conducting proteomic analyses. The goal is to identify biomarkers that could indicate the success of the transplant and potential complications.
Why it matters
Potential benefit: If successful, this approach could lead to better management and outcomes for kidney transplant recipients.
How similar studies have gone: Other studies have shown promise in using molecular monitoring techniques for transplant patients, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients after kidney transplantation, male, female, informed consent Exclusion Criteria: * Deny of informed consent
Where it's running
-
Odense University Hospital
Odense, Dk, Denmark Recruiting
Study contacts
- Principal investigator: Martin Tepel, Dr — Odense University Hospital
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving measures of nutrition, inflammation, kidney function, body composition, and hydration in older adults
This project will test whether modern blood tests and body-measure techniques give more accurate estimates of nutrition and kidney health for hospitalized people aged 65 and older.
-
Transformative 2.0 for diabetic kidney disease
This project will try to see if adults with diabetic kidney disease who take SGLT2 diabetes medicines have different biological patterns in archived kidney tissue than similar people who do not take these medicines.
-
21-day comprehensive spa care for kidney and urinary conditions
This program will try a 21-day spa treatment with mineral water baths, drinking cures, exercise and diet for adults 40–70 who have chronic kidney or urinary problems to see if it improves symptoms and kidney health.
-
Rutgers University Genetics of Kidney Disease
This project will see if genes are linked to kidney disease risk by collecting health surveys and saliva DNA from people 18 and older in the U.S.
-
Providing tailored produce boxes and nutrition education for Veterans with chronic kidney disease
This pilot will test whether delivering culturally and medically tailored produce boxes plus nutrition education helps Veterans with stage 3b–4 chronic kidney disease who have food or nutrition insecurity.
-
NightWare use for cardiovascular health in women with PTSD-related nightmares
This study tests whether NightWare can improve heart and kidney health biomarkers in premenopausal women who have PTSD-related nightmares.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.